---
$id: https://graph.org.ai/products/commodity/51131725
$type: Product
source: UNSPSC
code: "51131725"
title: "Epoprostenol or prostacyclin"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epoprostenol or prostacyclin

**UNSPSC Code**: 51131725
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula C20H32O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DCR9Z582X0. European Medicines Agency schedules epoprostenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06581MIG. The term EPOPROSTENOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21. ). EPOPROSTENOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Epoprostenol or prostacyclin bears US NLM identifiers UMLS ID C0033567 and NCI Concept Code C61748. SMILES: CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O.

